Soy Shows Promise as Natural Anti-Microbial Agent Wednesday, April 27, 2016 Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.Potential Target for Revolutionary Antibiotics Tuesday, April 26, 2016 An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe. DNA Barcodes Gone Wild Monday, April 25, 2016 A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions. Biomarkers for Profiling Prostate Cancer Patients Monday, April 25, 2016 Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.Grant to Fund Million Peaks Project Friday, April 22, 2016 The European Research Council (ERC) has awarded a prestigious Advanced Grant to Prof. Peter Schoenmakers, Prof. Albert Polman and Prof. Huib Bakker, all three of whom work at the University of Amsterdam (UvA). Investment in MBLI Expands JSR Life Sciences Friday, April 22, 2016 JSR Micro has announced that it has expanded the JSR Life Sciences business division by becoming the majority shareholder of Boston area-based MBL International Corporation (MBLI). Immunexpress, AMC Collaborate Thursday, April 21, 2016 Company has announced collaboration with AMC for development of sepsis-related biomarker panels.PeptiMimesis secures €1.2M from Cap Innov’Est Thursday, April 21, 2016 The company will launch its breakthrough technology-platform dedicated to identifying next-generation therapeutic peptides. ProBioGen, Eucodis Sign Agreement Wednesday, April 20, 2016 Company has signed an exclusive license agreement with Eucodis Bioscience to commercialize C-LiNK, a novel antibody drug conjugation technology.